Don't miss

Replay


LATEST SHOWS

MEDIAWATCH

Anticipating the debate

Read more

EYE ON AFRICA

Abubakar Shekau says he is still leading Boko Haram

Read more

THE DEBATE

Peace at last? Colombia, FARC rebels sign historic peace accord (part 1)

Read more

THE DEBATE

Peace at last? Colombia, FARC rebels sign historic peace accord (part 2)

Read more

ENCORE!

Music show: Mykki Blanco, Van Morrison & The Weeknd’s duo with Daft Punk

Read more

FOCUS

FRANCE 24 exclusive: The last stand for Libya’s Oil Crescent

Read more

TALKING EUROPE

Greece’s minister of tourism: ‘Tourism is a government priority’

Read more

TALKING EUROPE

Terrorism, strike actions and migrant crisis: Is the EU becoming less attractive to tourists?

Read more

BUSINESS DAILY

Moody's cuts Turkey's credit rating to junk

Read more

Sanofi-Aventis withdraws anti-obesity drug from European shelves

Text by AFP

Latest update : 2008-10-24

EU authorities have suspended sales of pharmaceutical giant Sanofi-Aventis' anti-obesity drug Acomplia across the continent, due to an abnormal risk of psychiatric problems.

EU authorities suspended sales of pharmaceutical giant Sanofi-Aventis' anti-obesity drug Acomplia across the continent Thursday, the firm announced, adding that it had not ruled out a worldwide halt.

"Sales have been halted in all the pharmacies in the 18 countries of the European Union where it is distributed," a company spokesman told AFP.

Sanofi-Aventis said the European Medicines Agency (EMEA) had warned that patients taking the drug ran almost double the normal risk of psychiatric problems.

"The risks of taking Acomplia are now greater than the benefits that the drug can bring the patient according to its current guidelines," the company said, citing the EMEA.

Europe has allowed sales of Acomplia since 2006, but it has not been authorised in the United States where authorities believe it encourages suicidal thoughts, even in patients with no history of depression.

The company said it had not ruled out withdrawing the drug in the 14 non-EU countries where it is sold. It said users of the drug should consult a doctor or pharmacist.
 

Date created : 2008-10-24

COMMENT(S)